Tobacco Use, Use Disorders, and Smoking Cessation Interventions in Persons Living With HIV

Current HIV/AIDS Reports

Volumn 12, Issue 4, 2015, Pages 413-420

  Pacek, Lauren R ^a,b   Cioe, Patricia A ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Cessation; Dependence; HIV; Nicotine; Smoking

Indexed keywords

AMFEBUTAMONE; NICOTINE LOZENGE; NICOTINE PATCH; VARENICLINE;

BACTERIAL PNEUMONIA; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DRUG EFFICACY; HIGH RISK PATIENT; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW BIRTH WEIGHT; LUNG CANCER; MORBIDITY; MORTALITY; NICOTINE REPLACEMENT THERAPY; PREGNANCY OUTCOME; PREMATURE LABOR; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SMALL FOR DATE INFANT; SMOKING CESSATION; TELECONSULTATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; COMPLICATION; PROCEDURES; TOBACCO USE;

HIV INFECTIONS; HUMANS; SMOKING CESSATION; TOBACCO USE; TOBACCO USE DISORDER;

EID: 84947043204     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-015-0281-9     Document Type: Review

References (51)

1. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17–25.
2. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56(5):727–34. Population-based cohort study that found that HIV-infected smokers currently lose more life years to cigarette smoking than they do to HIV itself.
3. Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, et al. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015;29(2):221–9.
4. Shirley DK, Kaner RJ, Glesby MJ. Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. HIV/AIDS. 2013;57:275–82.
5. Centers for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, 1965-2011. 2013. http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/. Accessed 13 June 2015.
6. Centers for Disease Control and Prevention. Current cigarette smoking among adults in the United States. 2015. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/. Accessed 13 June 2015.
7. Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population United States. Ann Intern Med. 2015;162:335–44.
8. Helleberg M, Gerstoft J, Afzal S, Kronborg G, Larsen CS, Pedersen C, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS. 2014;28:1499–508.
9. Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23:582–90.
10. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Current cigarette smoking among HIV-positive current and former drug users: associations with individual and social characteristics. AIDS Behav. 2014;18:1368–77.
11. Pines H, Koutsky L, Buskin S. Cigarette smoking and mortality among HIV-infected individuals in Seattle, Washington (1996-2008). AIDS Behav. 2011;15:243–51.
12. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial. Am J Public Health. 2010;100(10):1896–903.
13. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824–35.
14. Tamí-Maury I, Vidrine DJ, Fletcher FE, Danysh H, Arduino R, Gritz ER. Poly-tobacco use among HIV-positive smokers: implications for smoking cessation efforts. Nicotine Tob Res. 2013;15(12):2100–6.
15. McQueen A, Shacham E, Summer W, Overton T. Beliefs, experience, and interest in pharmacotherapy among smokers with HIV. Am J Health Behav. 2014;38(2):284–96.
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119–27.
17. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989;84:791–800.
18. Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev. 2011;13:119–29.
19. Freiberg MS, McGinnis KA, Kraemer K, Samet JH, Conigliaro J, Ellison RC, et al. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2010;53(2):247–53.
20. Petoumenos K, Worm S, Reiss P, de Wit S, d’Armino Monforte A, Sabin C, et al. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Med. 2011;12:412–21.
21. De P, Farley A, Lindson N, Aveyard P. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med. 2013;11(15):1–12.
22. Cui Q, Carruthers S, McIvor A, Smaill F, Thabane L, Smieja M. Effect of smoking on lung function, respiratory symptoms, and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther. 2010;7(6):1–10.
23. Madeddu G, Fois AG, Calia GM, Babudieri S, Soddu V, Becciu F, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection. 2013;41:347–53.
24. National Cancer Institute. Harms of cigarette smoking and health benefits of quitting. 2014. http://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/cessation-fact-sheet. Accessed 20 June 2014.
25. Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–62.
26. Vandenhende MA, Roussillon C, Henard S, Morlat P, Oskenhendler E, Aumaitre H, et al. Cancer-related causes of death among HIV-infected patients in France in 2010: evolution since 2010. PLoS One. 2015;10(6):1–12. Combined data from three national surveys conducted in France that showed that the proportion of deaths attributed to AIDS-defining cancers decreased between 2000 and 2010, while the proportion of deaths attributed to non-AIDS/non-hepatitis-related cancers increased significantly during the same time frame.
27. Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer. 2010;103:416–22.
28. Clifford GM, Lise M, Franceschi S, Egger M, Bouchardy C, Korol D, et al. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency, and pulmonary infection. Br J Cancer. 2012;106:447–52.
29. Reekie J, Kosa C, Engsig F, Monforte AD, Wiercinska-Drapalo A, Domingo P, et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer. 2010;116:5306–15.
30. Bryant VE, Kahler CW, Devlin KN, Monti PM, Cohen RA. The effects of cigarette smoking on learning and memory performance among people living with HIV/AIDS. AIDS Care. 2013;25(10):1308–16.
31. Benedict RHB, Schretlen A, Groninger L, Brandt J. Hopkins verbal learning test revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998;12:43–55.
32. Benedict RHB. Brief visuospatial memory test—revised. Odessa: Psychological Assessment Resources; 1997.
33. Maria Jose MB, Richardson E, Vargas M, Espinoza L, Lewis JE, Deshratan A, et al. Mentholated cigarettes are related with abnormal brain-derived neurotrophic factor levels among smokers living with HIV. J Alcohol Drug Depend. 2014;2(5):1–6.
34. Atluri VSR, Pilakka-Kanthikeel S, Samikkannu T, Sagar V, Kurapati KRV, Saxena SK, et al. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder. Mol Brain. 2014;7(37):1–17.
35. Aliyu MH, Weldeselasse H, August EM, Keith LG, Salihu HM. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine Tob Res. 2013;15(1):177–84.
36. Shapiro AE, Tshabangu N, Golub JE, Martinson NA. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. Int J Tuberc Lung Dis. 2011;15(1):140–2.
37. Matthews AK, Vargas MC, Kuhns L, Shivappa N, King A. A qualitative examination of barriers and motivators to smoking cessation among HIV positive African American MSM smokers. J Health Dispar Res Pract. 2014;7(2):50–76.
38. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug Alcohol Depend. 2014;138:220–4.
39. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36(1):75–85.
40. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.
41. Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67(1):59–66.
42. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61:208–15.
43. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25(7):820–7.
44. Humfleet GL, Hall SM, Kelucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8):1436–45.
45. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS. 2013;27(1):22–32.
46. Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, et al. Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS. 2011;26(1):12–9.
47. Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, et al. Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res. 2013;15(1):247–54.
48. Cropsey KL, Hendricks PS, Jardin B, Clark CB, Katiyar N, Willig J, et al. A pilot study of Screening, Brief Intervention, and Referral for Treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38:2541–6.
49. Cropsey KL, Jardin B, Burkholder G, Clark CB, Raper JL, Saag M. An algorithm approach to determining smoking cessation treatment for persons living with HIV/AIDS: results of a pilot trial. J Acquir Immune Defic Syndr. 2015;69(3):291–8.
50. Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology. 2011;217:279–87.
51. Dunn KE, Sigmon SC, Reimann EF, Badger GJ, Heil SH, Higgins ST. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Exp Clin Psychopharmacol. 2010;18(1):37–50.